How to Cite
Abstract
Цель обзора — на основании данных мировой литературы оценить перспективность нового метода — артериальной радиоэмболизации — у больных первичным и метастатическим раком печени.References
Гранов А.М., Давыдов М.И. (Ред). Интервенционная радиология в онкологии. СПб.: Фолиант. — 2013. — 560 С.
Гранов Д.А. Трансплантация печени при гепатоцеллюлярном раке // Практ. онкол. — 2008. — Т 9. — С. 237-240.
Долгушин Б.И., Патютко Ю.И., Шолохов В.Н., Косырев В.Ю. Радиочастотная термоаблация опухолей печени. М.: Практ. мед. —2007. — 192 С.
Поликарпов А.А., Таразов П.Г., Гранов Д.А., Попов В.В. Рентгеноэндоваскулярные вмешательства в лечении больных с нерезектабельными метастазами неколоректального рака в печень // Анн. хирург. гепатол. — 2010. — Т. 15, № 4. — С. 33-41.
Таразов П.Г. Роль методов интервенционной радиологии в лечении больных с метастазами колоректального рака в печень // Практ. онкол. — 2005. — Т. 6. — С. 119-126.
Таразов П.Г., Поликарпов А.А. Рентгеноэндоваскулярные вмешательства в лечении первичного рака печени // Альманах ин-та хирургии им. А.В. Вишневского. — 2010. — Т. 5. — № 2. — С. 7-15.
Abdelmaksoud M.H.K., Louie J.D., Kothary N., et al. Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization // J. Vasc. Interv. Radiol. — 2011. — Vol. 22. — P. 1364-1371.
Ariel I.M., Pack G.T. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy // Cancer (Philad.). — 1967. — Vol. 20. — P. 793-804.
Atassi B., Bangash A.K., Lewandowski R.J., et al. Biliary sequelae following radioembolization with Yttrium-90 microspheres // J. Vasc. Interv. Radiol. — 2008. — Vol. 19. — P. 691-697.
Bangash A.K., Atassi B., Kaklamani V., et al. 90Y radioembolization of metastatic breast cancer to the liver: Toxicity, imaging response, survival // J. Vasc. Interv. Radiol. — 2007. — Vol. 18. — P. 621-628.
Bester L., Meteling B., Pocock N., et al. Radioembolization versus standard care of hepatic metastases: Comparative retrospective cohort study of survival outcomes and adverse events in salvage patients // Ibid. — 2012. — Vol. 23. — P. 96-105.
Bilbao J.I., Garrastachu P., Herraiz M.J., et al. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors // Cardiovasc. Intervent. Radiol. — 2010. — Vol. 33. — P. 523-531.
Brown R.E., Bower M.R., Metzger T.L., et al. Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: Is it safe? // Hepatic Pancreatic Biliary. — 2011. — Vol. 13. — P. 91-95.
Burton M.A., Gray B.N., Klemp P.F., et al. Selective internal radiation therapy: Distribution of radiation in the liver // Europ. J. Cancer Clin. Oncol. — 1989. — Vol. 25. — P. 1487-1491.
Buscombe J.R. Interventional nuclear medicine in hepatocellular carcinoma and other tumors // Nucl. Med. Commun. — 2002. — Vol. 23. — P. 837-841.
Carr B.I., Kondragunta Y., Bush S.C., Branch R.A. Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium microsphere treatments in unresectable hepatocellular carcinoma // Cancer (Philad.). — 2010. — Vol. 116. — P. 1305-1314.
Cianni R., Urigo C., Notarianni E., et al. Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases // Cardiovasc. Intervent. Radiol. — 2009. — Vol. 32. — P. 1179-1186.
Cianni R., Pelle G., Notarianni E., et al. Radioembolisation with 90Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer // Europ. Radiol. — 2013. — Vol. 23. — P. 182-189.
Cosimelli M., Golfieri R., Cagol P.P., et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases // Brit. J. Cancer. — 2010. — Vol. 103. — P. 324-331.
Evans K.A., Richardson M.G., Pavlakis N., et al. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres // J. Vasc. Interv. Radiol. — 2010. — Vol. 21. — P. 1521-1526.
Garin E. Radioembolisation of hepatocellular carcinoma patients using 90Y-labelled microspheres: Towards a diffusion of the technique? // Europ. J. Nucl. Med. Mol. Imaging. — 2011. — Vol. 38. — P. 2114-2116.
Geschwind J.F., Salem R., Carr B.I., et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma // Gastroenterology. — 2004. — Vol. 127, Suppl. 1. — P. 194-205.
Gonsalves C.F., Eschelman D.J., Sullivan K.L., et al. Radioembolization as salvage therapy for hepatic metastases of uveal melanoma: A single-institution experience // Amer. J. Roentgenol. — 2011. — Vol. 196. — P. 468-473.
Herba M.J., Thirlwell M.P. Radioembolization of hepatic metastases // Semin. oncol. — 2002. — Vol. 29. — P. 152-159.
Hilgard P., Hamami M., El Fouli A., et al. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival // Hepatology. — 2010. — Vol. 52. — P. 1741-1749.
Hoffmann R.-T., Jakobs T.F., Kubisch C.H., et al. Radiofrequency ablation after selective internal radiation therapy with yttrium 90 microspheres in metastatic liver disease — is it feasible? // Europ. J. Radiol. — 2010. — Vol. 74. — P. 199-205.
Hoffmann R.-T., Paprottka P.M., Schön A., et al. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: Factors associated with prolonged survival // Cardiovasc. Intervent. Radiol. — 2012. — Vol. 35. — P. 105-116.
Ibrahim S.M., Mulcahy M.F., Lewandowski R.J., et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: Results from a pilot study // Cancer (Philad.). — 2008. — Vol. 113. — P. 2119-2128.
Ibrahim S.M., Kulik L., Baker T., et al. Treating and down-staging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization // Cardiovasc. Intervent. Radiol. — 2012. — Vol. 35. — P. 1094-1101.
Ingold J.A., Reed G.B., Kaplan H.S., Bagshow M.A. Radiation hepatitis // Amer. J. Roentgenol. — 1965. — Vol. 93. — P. 200-208.
Inarrairaequi M., Thurston K.G., Bilbao J.T., et al. Radioembolization with use of yrrtium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis // J. Vasc. Interv. Radiol. — 2010. — Vol. 21. — P. 1205-1212.
Inarrairaequi M., Pardo F., Bilbao J.T., et al. Response to radioembolization with yrrtium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma // Europ. J. Surg. Oncol. — 2012. — Vol. 38. — P. 594-601.
Jakobs T.F., Hoffmann R.T., Fisher T., et al. Radioembolization in patients with hepatic metastases from breast cancer // J. Vasc. Interv. Radiol. — 2008. — Vol. 19. — P. 683-690.
Jakobs T.F., Saleem S., Atassi B., et al. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90Yttrium microspheres // Dig. Dis. Sci. — 2008. — Vol. 53. — P. 2556-2563.
Kalinowski M., Dressler M., Konig A., et al. Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: A prospective single center study // Digestion. — 2009. — Vol. 79. — P. 137-142.
Kennedy A., Coldwell D., Sangro B., et al. Integrating radioembolization into the treatment paradigm for metastatic neuroendocrine tumors in the liver // Amer. J. Clin. Oncol. — 2012. — Vol. 35. — P. 393-398.
King J., Quinn R., Glenn D.M., et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases // Cancer (Philad.). — 2008. — Vol. 113. — P. 921-929.
Konda A., Savin M.A., Cappell M.S., Duffy M.C. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: An underrecognized clinical entity // Gastrointest. Endosc. — 2009. — Vol. 70. — P. 561-567.
Kulik L.M., Carr B.I., Mulcahy M.F., et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. // Hepatology. — 2008. — Vol. 47. — P. 71-81.
Lambert B., Praet M., Vanlangenhove P., et al. Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: Pathology of the explant livers and clinical outcome // Cancer Biother. Ra-diopharm. — 2005. — Vol. 20. — P. 209-214.
Lance C., McLennan G., Obuchowski N., et al. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma // J. Vasc. Interv. Radiol. — 2011. — Vol. 22. — P. 1697-1705.
Lau W.Y., Ho S., Leung T.W., et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90Yttrium microspheres // Int. J. Radiat. Oncol. Biol. Phys. — 1998. — Vol. 40. — P. 583-592.
Lewandowski R.J., Sato K.T., Atassi B., et al. Radioembolization with 90Y microspheres: Angiographic and technical considerations. // Cardiovasc. Intervent. Radiol. — 2007. — Vol. 30. — P. 571-592.
Lewandowski R.J., Kulik L.M., Riaz A., et al. A com parative analysis of transarterial downstaging for hepatocellular carcinoma: Chemoembolization versus radioembolization // Amer. J. Transplant. — 2009. — Vol. 9. — P. 1920-1928.
Lewandowski R.J., Geschwind J.F., Liapi E., Salem R. Transcatheter intraarterial therapies: Rationale and overview // Radiology. — 2011. — Vol. 259. — P. 641-657.
Marn C.S., Andrews J.C., Francis I.R., et al. Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings // Ibid. — 1993. — Vol. 187. — P. 125-128.
Mascarenhas N., Ryu R.K., Salem R. Hepatic radioembolization complicated by abscess // Semin. Intervent. Radiol. — 2011. — Vol. 28. — P. 222-225.
Memon K., Kulik L., Lewandowski R.J., et al. Radioembolization for hepatocellular carcinoma with portal vein thrombosis: Impact of liver function on systemic treatment options at disease progression // J. Hepatol. — 2013. — Vol. 58. — P. 73-80.
Mulcahy M.F., Lewandowski R.J., Ibrahim S.M., et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres // Cancer (Philad.). — 2009. — Vol. 115. — P. 1849-1858.
Nalesnik M.A., Federle M., Buck D., et al. Hepatobiliary effects of 90 yttrium microsphere therapy for unresectable hepatocellular carcinoma // Hum. Pathol. — 2009. — Vol. 40. — P. 125-134.
Naymagon S., Warner R.R.P., Patel K., et al. Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: An institutional experience and review of the literature // Dig. Dis. Sci. — 2010. — Vol. 55. — P. 2450-2458.
Paprottka P.M., Hoffmann R.-T., Haug A., et al. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres // Cardiovasc. Intervent. Radiol. — 2012. — Vol. 35. — P. 334-342.
Phillips R., Murikami K. Primary neoplasms of the liver: Results of radiation therapy // Cancer (Philad.). — 1960. — Vol. 13. — P. 714-720.
Piana P.M., Gonsalves C.F., Sato T., et al. Toxicities after radioembolization with yttrium-90 SIR spheres: Incidence and contributing risk factors at a single center // J. Vasc. Interv. Radiol. — 2011. — Vol. 22. — P. 1373-1379.
Powerski M.J., Scheurig-Muenkel C., Banzen J., et al. Clinical practice in radioembolization of hepatic malignancies: A survey among interventional centers in Europe // Europ. J. Radiol. — 2012. — Vol. 81. — P. e804-e811.
Salem R., Thurston K.G., Carr B.I., et al. Yttrium-90 microspheres: Radiation therapy for unresectable liver cancer // J. Vasc. Intervent. Radiol. — 2002. — Vol. 13, No. 9, Pt. 2. — P. 223-229.
Salem R., Lewandowski R.J., Mulcahy M.F., et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: A comprehensive report of long-term outcomes // Gastroenterology. — 2010. — Vol. 138. — P. 52-64.
Salem R., Lewandowski R.J., Kulik L., et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma // Gastroenterology. — 2011. — Vol. 140. — P. 497-507.
Sangro B., Gil-Alzugaray B., Rodriguez J., et al. Liver disease induced by radioembolization of liver tumors // Cancer (Philad). — 2008. — Vol. 112. — P. 1538-1546.
Sangro B., Carpanese L., Cianni R., et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona Clinic Liver Cancer stages: A European evaluation // Hepatology. — 2011. — Vol. 54. — P. 868-878.
Sato K.T., Lewandowski R.J., Mulcahy M.F., et al. Unresectable chemorefractory liver metastases: Radioembolization with 90Y microspheres — safety, efficacy, and survival // Radiology. — 2008. — Vol. 247. — P. 507-515.
Saxena A., Bester L., Chua T.C., et al. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: A preliminary assessment of this novel treatment option // Ann. Surg. Oncol. — 2010. — Vol. 17. — P. 484-491.
Seidensticker R., Denecke T., Kraus P., et al. Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver dominant colorectal metastases // Cardiovasc. Intervent. Radiol. — 2012. — Vol. 35. — P. 1066-1073.
Seidensticker R., Seidensticker M., Damm R., et al. Hepatic toxicity after radioembolization of the liver using 90Y-microspheres: Sequential lobar versus whole liver approach // Ibid. — 2012. — Vol. 35. — P. 1109-1118.
Stubbs R.S., Wickremesekera S.K. Selective internal radiation therapy (SIRT): A new modality for treating patients with colorectal liver metastases (review) // Hepatic Pancreatic Biliary. — 2004. — Vol. 6. — P. 133-139.
Tsai A.L., Burke C.T., Kennedy A.S., et al. Use of yttrium-90 mocrospheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis // J. Vasc. Interv. Radiol. — 2010. — Vol. 21. — P. 1377-1384.
Wasan H., Kennedy A., Coldwell D., et al. Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases // Am. J. Clin. Oncol. — 2012. — Vol. 35. — P. 293-301.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...